Product Information

CHLD ACETAMINOPHEN 160 MG/5 ML is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0214 per ML under NDC 45802020126. Its NADAC has been published 629 times since Jun 11, 2014.

The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CHLD ACETAMINOPHEN 160 MG/5 ML

Acetaminophen
$0.0214per ML
High Outlier
OTC

Strength

160 mg/5mL

NDC

45802020126

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ACETAMINOPHEN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

4/9/2014

Price Statistics

The NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has been published 629 times since Jun 11, 2014, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0214 per ML
All-time high$0.0261 (Mar 15, 2023)
All-time low$0.0178 (Jul 19, 2017)
52-week high$0.0214
52-week low$0.0192
Median price$0.0199
Average price$0.0200
Largest weekly change+25.7% (Feb 22, 2023)
Weeks tracked629
Tracking sinceJun 11, 2014

Price History

1W

0.0%

1M

+1.2%

3M

+0.4%

6M

+1.9%

1Y

+2.3%

3Y

+2.2%

5Y

+3.9%

All

+9.7%

Generic Alternatives

The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CHLD ACETAMINOPHEN 160 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for CHLD ACETAMINOPHEN 160 MG/5 ML, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0214 per ML (NDC 45802020126), effective Jun 24, 2026.

How has the price of CHLD ACETAMINOPHEN 160 MG/5 ML changed over time?

Over the history we have for it, the NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has risen 9.7%. It has been tracked across 629 weekly CMS publications since Jun 11, 2014.

What are the highest and lowest recorded NADAC prices for CHLD ACETAMINOPHEN 160 MG/5 ML?

Since Jun 11, 2014, the NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has ranged from a low of $0.0178 (Jul 19, 2017) to a high of $0.0261 (Mar 15, 2023), with a median of $0.0199 per ML.

Are there cheaper alternatives to CHLD ACETAMINOPHEN 160 MG/5 ML?

Yes. 14 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ACETAMINOPHEN 160 MG/5 ML LIQ, is $0.0114 per ML — about 47% below CHLD ACETAMINOPHEN 160 MG/5 ML.

Who manufactures CHLD ACETAMINOPHEN 160 MG/5 ML?

CHLD ACETAMINOPHEN 160 MG/5 ML (NDC 45802020126) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.